Bristol-Myers raises its quarterly dividend
Bristol-Myers Squibb Company has declared an increase of 2.6% percent in the its quarterly dividend, beginning in the first quarter…
Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers Squibb Company has declared an increase of 2.6% percent in the its quarterly dividend, beginning in the first quarter…
European Patent Office has granted ValiRx’s patent covering its major therapeutic compound VAL201, including prostate cancer, the pharmaceutical company said on…
InnovaDerma, a UK -based company focused on hair loss, hair care, self-tanning and skin rejuvenation, has raised £539,999.60 through the…
Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) have made a deal for Bayer to buy BIVI’s Cydectin bovine and ovine…
Biocartis Group NV has launched its second liquid biopsy assay, the Idylla ctKRAS Mutation Assay, which was developed in partnership…
The U.S. Food and Drug Administration (FDA) has granted “Fast Track” status to French biopharmaceutical company Neovacs’s IFNalpha Kinoid in…
Essilor, a medical supplies company, has decided to realign its organization to meet the growing operational needs as the company…
GeNeuro and Servierhave set up a study they named ANGEL-MS, which is a long-term extension study for patients with multiple sclerosis…
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
Allergan has announced the availability of TAYTULLATM (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules)…